Sinoway Industrial Co., Ltd.

Imatinib Mesylate 220127-57-1 Imatinib Mesylate 220127-57-1

Imatinib Mesylate 220127-57-1
Produk Terkait
  • L-Glutathione dikurangkan (GSH) 70-18-8

    L-Glutathione DikurangkanBasa maklumat L-Glutathione dikurangkan: Nama produk: L-Glutathione ReducedMolecular Formula: C20H32N6O12S2Molecular Berat: 612.63CAS No.:70-18-8ENIECE No: 200-725-4Appearanc ...

  • Copper Peptide (GHK) 2-CU 49557-75-7

    Maklumat tembaga peptida GHK-CuBasic maklumat peptida tembaga GHK-Cu: Nama Produk (GHK) 2-Cu (Tembaga Peptida) SinonimGHK-Cu (tembaga peptida) CAS # 49557-75-7Molecular FormulaC28H46N12O8Cu Molecular Weight742.2 ...

  • Isoflavon dalam Kacang 574-12-9

    Ekstrak kacang soya Extract1.Basic maklumat mengenai Ekstrak Kedelai: Nama produk: Extract SoybeanSource: glycine maxUsed part: germ / bean pulpSpec .: total soy isoflavone 40%, 80% oleh HPLCNameSoybean Extract PowderTyp ...

Maklumat asas Imatinib Mesylate

Name

Imatinib Mesylate

Alias

GLIVEC;GLEEVEC;IMATINIB METHANESULFONATE; CGP-57148B;
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-phenyl]-benzamide Mesylate;

CAS NO.

220127-57-1

Molecular Formula

C30H35N7O4S

Molecular Weight

589.71

Quality Standard

In-house Standard

Package Size

Aluminium bag; 50g/bag; 100g/bag

Brief Introduction

Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl,
the causal agent in chronic myelogenous leukemia.
As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of
dermatological diseases. Imatinib has been reported to be an effective treatment for
FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.

Storage condition

Preserve in tight, light-resistant containers, and store at 15℃—30℃.

Penggunaan Imatinib Mesilate

  • Inhibitor tyrosine kinase. Sangat khusus untuk BCR-ABL, enzim yang berkaitan dengan leukemia myelogenous kronik (CML) dan bentuk tertentu leukemia limfoblastik akut (SEMUA)
  • echinocandin antifungal, aktif terhadap jangkitan dengan Aspergillus dan Candida, menghalang sintesis dinding sel
  • Antikanker

COA Imatinib Mesylate

TEST ITEM

SPECIFICATION

RESULTS

Appearance

White or slightly yellow crystalline powder,
homogeneous and with fine grain size.
No foreign particles are observed.

Slightly yellow crystalline Powder

Solubility

Soluble in water and in acids solutions, slightly soluble
in methanol insoluble in acetone, acetonitrile and
dilute hydroxyl alkaline solution

Confirm

Identification

Complies

Confirm

Water

≤1.0%

0.8%

Heavy metals

≤20ppm

10ppm

Melting range

212 – 220℃

214-216℃

Residue on ignition

≤0.1%

0.08%

Particle size

90% < 100 μm

50% < 50 μm

Confirm

Bulk density

NLT 0.4g/ml

0.6g/ml

Chromatographic

purity

Individual impurities: ≤0.2%

Total impurities: ≤0.5%

0.16%

0.32%

Assay

98.5%-102.0% of Imatinib mesylate,

calculated on anhydrous basis.

99.70%



Residual solvents

Ethyl acetate: ≤5000ppm

Confirm

Acetone: ≤5000ppm

Confirm

N,N-Dimethylformamide: ≤880ppm

Confirm

Methanol: ≤3000ppm

Confirm

Dichloromethane: ≤300ppm

Confirm



MORE_DETAIL Imatinib Mesylate 220127-57-1

Maklumat asas Imatinib Mesylate

Name

Imatinib Mesylate

Alias

GLIVEC;GLEEVEC;IMATINIB METHANESULFONATE; CGP-57148B;
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-phenyl]-benzamide Mesylate;

CAS NO.

220127-57-1

Molecular Formula

C30H35N7O4S

Molecular Weight

589.71

Quality Standard

In-house Standard

Package Size

Aluminium bag; 50g/bag; 100g/bag

Brief Introduction

Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl,
the causal agent in chronic myelogenous leukemia.
As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of
dermatological diseases. Imatinib has been reported to be an effective treatment for
FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.

Storage condition

Preserve in tight, light-resistant containers, and store at 15℃—30℃.

Penggunaan Imatinib Mesilate

  • Inhibitor tyrosine kinase. Sangat khusus untuk BCR-ABL, enzim yang berkaitan dengan leukemia myelogenous kronik (CML) dan bentuk tertentu leukemia limfoblastik akut (SEMUA)
  • echinocandin antifungal, aktif terhadap jangkitan dengan Aspergillus dan Candida, menghalang sintesis dinding sel
  • Antikanker

COA Imatinib Mesylate

TEST ITEM

SPECIFICATION

RESULTS

Appearance

White or slightly yellow crystalline powder,
homogeneous and with fine grain size.
No foreign particles are observed.

Slightly yellow crystalline Powder

Solubility

Soluble in water and in acids solutions, slightly soluble
in methanol insoluble in acetone, acetonitrile and
dilute hydroxyl alkaline solution

Confirm

Identification

Complies

Confirm

Water

≤1.0%

0.8%

Heavy metals

≤20ppm

10ppm

Melting range

212 – 220℃

214-216℃

Residue on ignition

≤0.1%

0.08%

Particle size

90% < 100 μm

50% < 50 μm

Confirm

Bulk density

NLT 0.4g/ml

0.6g/ml

Chromatographic

purity

Individual impurities: ≤0.2%

Total impurities: ≤0.5%

0.16%

0.32%

Assay

98.5%-102.0% of Imatinib mesylate,

calculated on anhydrous basis.

99.70%



Residual solvents

Ethyl acetate: ≤5000ppm

Confirm

Acetone: ≤5000ppm

Confirm

N,N-Dimethylformamide: ≤880ppm

Confirm

Methanol: ≤3000ppm

Confirm

Dichloromethane: ≤300ppm

Confirm


Artikel Berkaitan
Tinggalkan Mesej Emel kami

kami akan menghubungi anda dalam masa 24 jam.

  • TEL:+ 86-0592-5854962
  • FAX:+ 86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Tingkat 16, Pusat Perniagaan Huicheng, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//